Calcidol 200 mcg (8000 UNT) in 1 mL Oral Solution
RxNorm 877408
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 877408 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Calcidol 200 mcg (8000 UNT) in 1 mL Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Calcidol 0.2 mg/ML Oral Solution
(Atom ID: 11817018)
PSNPrescribable
Prescribable Name (PSN):
Calcidol 200 mcg (8000 UNT) in 1 mL Oral Solution
(Atom ID: 11840399)
SYPrescribable
Synonym (SY):
Calcidol 8000 UNT per 1 mL Oral Solution
(Atom ID: 8720449)
SYPrescribable
Synonym (SY):
Calcidol 8000 UNT/ML Oral Solution
(Atom ID: 3022659)
SBDPrescribable
Semantic Branded Drug (SBD):
Ergocalciferol 0.2 mg/ML Oral Solution [Calcidol]
(Atom ID: 12362938)
SYPrescribable
Synonym (SY):
Vit-D 0.2 mg/ML Oral Solution [Calcidol]
(Atom ID: 11817919)
SYPrescribable
Synonym (SY):
Vitamin D 0.2 mg/ML Oral Solution [Calcidol]
(Atom ID: 11817924)
Patient Education
Ergocalciferol
Ergocalciferol is used in the treatment of hypoparathyroidism (condition in which the body does not produce enough parathyroid hormone), refractory rickets (softening and weakening of bones that does not respond to treatment), and familial hypophosphatemia (rickets or osteomalacia caused by an inherited condition with a decreased ability to break down vitamin D in the body). Ergocalciferol is in a class of medications called vitamin D analogs. It works by helping the body to use more of the calcium found in foods or supplements.
[Learn More]
Vitamin D
[Learn More]
* Please review the disclaimer below.